Drugs Made In America Acq... (DMIIU)
NasdaqGM: DMIIU
· 실시간 가격 · USD
10.17
-0.01 (-0.10%)
종가 기준: Aug 12, 2026, 10:47 AM
기업 설명
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Drugs Made In America Acquisition II Corp.

| 국가 | United States |
| IPO 일자 | 2025년 9월 25일 |
| 산업 | Shell Companies |
| 섹터 | Financial Services |
| 직원 수 | n/a |
| CEO | Mr. Roger Bendelac |
연락처
주소: 420 Lexington Avenue New York, NY United States | |
| 웹사이트 | n/a |
주식 정보
| 티커 | DMIIU |
| 거래소 | NasdaqGM |
| 회계연도 | Jan '25 - Dec '25 |
| 보고 통화 | USD |
| CIK 코드 | 0002040475 |
| CUSIP 번호 | n/a |
| ISIN 번호 | n/a |
| 고용주 식별번호 | n/a |
| SIC 코드 | n/a |
주요 임원
| 이름 | 직책 |
|---|---|
| Mr. Roger Bendelac | Chief Executive Officer |
| Mr. Saleem Elmasri CPA | CFO & Principal Accounting Officer |